Dar Al Dawa Development and Investment (AMM:DADI) FCF Margin %: 32.57% (As of Mar. 2026) — 1827% Above Median


AMM:DADI Dar Al Dawa Development and Investment AMM:DADI
77 GF Score
Price JOD1.14
GF Value JOD1.10
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Dar Al Dawa Development and Investment FCF Margin %?

Dar Al Dawa Development and Investment AMM:DADI 77 FCF Margin % is 32.57% as of Mar. 2026, which is 1827% above its 10-year median of 1.69. GuruFocus rates AMM:DADI with a GF Score™ of 77/100 and a GF Value™ of JOD1.10 (Fairly Valued). The stock has 4 warning signs investors should review. Among 960 Drug Manufacturers companies, Dar Al Dawa Development and Investment ranks better than 80.21% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dar Al Dawa Development and Investment's Free Cash Flow for the three months ended in Mar. 2026 was JOD4.91 Mil. Dar Al Dawa Development and Investment's Revenue for the three months ended in Mar. 2026 was JOD15.07 Mil. Therefore, Dar Al Dawa Development and Investment's FCF Margin % for the quarter that ended in Mar. 2026 was 32.57%.

As of today, Dar Al Dawa Development and Investment's current FCF Yield % is 19.70%.

The historical rank and industry rank for Dar Al Dawa Development and Investment's FCF Margin % or its related term are showing as below:

AMM:DADI' s FCF Margin % Range Over the Past 10 Years
Min: -13.21   Med: 1.69   Max: 14.32
Current: 14.32


During the past 13 years, the highest FCF Margin % of Dar Al Dawa Development and Investment was 14.32%. The lowest was -13.21%. And the median was 1.69%.

AMM:DADI's FCF Margin % is ranked better than
80.21% of 960 companies
in the Drug Manufacturers industry
Industry Median: 2.48 vs AMM:DADI: 14.32


Dar Al Dawa Development and Investment FCF Margin % Related Terms


Dar Al Dawa Development and Investment FCF Margin % Historical Data

* Premium members only.

The historical data trend for Dar Al Dawa Development and Investment's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dar Al Dawa Development and Investment FCF Margin % Chart

Dar Al Dawa Development and Investment Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.64 10.02 3.81 0.45 2.93

Dar Al Dawa Development and Investment Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.10 -1.74 -9.15 32.79 32.57

AMM:DADI vs ZTS, UTHR, VTRS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al Dawa Development and Investment's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dar Al Dawa Development and Investment FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dar Al Dawa Development and Investment's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dar Al Dawa Development and Investment's FCF Margin % falls into.


AMM:DADI
77GF Score
Dar Al Dawa Development and Investment AMM:DADI
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dar Al Dawa Development and Investment FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dar Al Dawa Development and Investment's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=2.392/81.563
=2.93 %

Dar Al Dawa Development and Investment's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=4.907/15.068
=32.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 32.57% mean?
Dar Al Dawa Development and Investment (AMM:DADI) has a FCF Margin % of 32.57% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dar Al Dawa Development and Investment and its competitors. This is 1827% above median its historical median of 1.69. According to the industry distribution chart, Dar Al Dawa Development and Investment ranks #190 out of 960 companies in the Drug Manufacturers industry, placing it in the top 19.8%.
Is Dar Al Dawa Development and Investment's FCF Margin % too high?
Dar Al Dawa Development and Investment's current FCF Margin % of 32.57% is 1827% above median its 10-year median of 1.69. The Drug Manufacturers industry median FCF Margin % is 2.48. Dar Al Dawa Development and Investment's value of 32.57% is 1213.3% above this industry median. Based on the distribution chart, Dar Al Dawa Development and Investment ranks #190 out of 960 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Dar Al Dawa Development and Investment has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dar Al Dawa Development and Investment's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Dar Al Dawa Development and Investment ranks #190 out of 960 companies for FCF Margin %. This places Dar Al Dawa Development and Investment in the top 20% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.48. Dar Al Dawa Development and Investment's value of 32.57% is 1213.3% above this benchmark. While the company's 10-year median is 1.69 vs. the industry median of 2.48, Dar Al Dawa Development and Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dar Al Dawa Development and Investment's current FCF Margin % of 32.57% is 1213.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dar Al Dawa Development and Investment and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dar Al Dawa Development and Investment's current FCF Margin % is 32.57%, which is 1827% above median its own 10-year median of 1.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dar Al Dawa Development and Investment stock overvalued right now?
Based on GuruFocus' analysis, Dar Al Dawa Development and Investment (AMM:DADI) is currently considered Fairly Valued. The stock's GF Value™ is JOD1.10, compared to a current price of JOD1.14 — trading 3.6% above its estimated fair value. The current FCF Margin % is 32.57%, which is 1827% above median its 10-year median of 1.69 and 1213.3% above the Drug Manufacturers industry median of 2.48. Dar Al Dawa Development and Investment's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Dar Al Dawa Development and Investment (AMM:DADI), the current FCF Margin % is 32.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dar Al Dawa Development and Investment (AMM:DADI) Overvalued in 2026?

Based on GuruFocus' analysis, Dar Al Dawa Development and Investment stock appears to be overvalued. The current stock price of JOD1.14 is trading 3.6% above its estimated GF Value™ of JOD1.10. GuruFocus considers Dar Al Dawa Development and Investment to be Fairly Valued.

Key valuation signals for AMM:DADI:

  • FCF Margin %: 32.57% (1827% above median its 10-year median of 1.69)
  • GF Value™: JOD1.10 vs. price of JOD1.14 (3.6% above fair value)
  • GF Score™: 77/100 with 4 warning signs
  • Industry Position: 1213.3% above the Drug Manufacturers median (#190 of 960)

No single metric tells the full story. See the AMM:DADI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dar Al Dawa Development and Investment Business Description

Address Naour, P.O. Box 9364, Amman, JOR, 11191
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives are the production of medical, chemical, and pharmaceutical products, and importing pharmaceutical products. The subsidiaries' main objectives are marketing and distributing the Company's products, producing some specialized medical products, and investment activities. It offers products in the therapeutic areas of anti-infective, cardiovascular, diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.
77GF Score

Get the complete analysis for AMM:DADI

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD1.14
Price
JOD1.10
GF Value